Making advances in pediatric cancer

GRAND RAPIDS, Mich. (WOOD) West Michigan is very fortunate to have an incredible resource for health care for families and children, with the Helen DeVos Children’s Hospital.

They have one of the largest children’s cancer treatment programs in the Midwest, including the Haworth Innovative Translational Research Program. The program conducts research on pediatric cancer, helping develop new therapies and test medication. The research is then brought to Helen DeVos Children’s Hospital’s pediatric oncology clinic to help treat patients there.

Helen DeVos Children’s Hospital is part of a NMTRC Symposium happening April 27 – 29 in Grand Rapids. They will be discussing neuroblastoma, which is a type of pediatric cancer that has a high rate of relapse. The research done at the Haworth Innovative Translational Research Program has been highly successful at preventing relapse in children with neuroblastoma at Helen DeVos Children’s Hospital.

blog comments powered by Disqus